The root word for our company is “doulos” and it means “to serve.”
Our mission is to serve the rare disease and neurodegenerative disorder communities, in other words, to do lots, by driving greater success in clinical trials and thereby treatments and cures.
We do this by developing accurate and sensitive outcome measures, guiding relevant constituencies on effective and efficient design for clinical trials and natural history studies, and training clinical trial teams.